pfizer covid - Search News

News

Pfizer, Q2

Pfizer's Turnaround Has Truly Started (Earnings Update)

Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE stock is a Buy.

Houston Chronicle · 2d

Pfizer: Q2 Earnings Snapshot

The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 58 cents per share. The drugmaker posted revenue of $14.65 billion in the period, also topping Street forecasts.

Zacks.com on MSN · 1d

Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth

Pfizer PFE reported second-quarter 2025 adjusted earnings per share of 78 cents, which comprehensively beat the Zacks Consensus Estimate of 58 cents per share. Earnings rose 30% year over year. Revenues came in at $14.

Pfizer Raises Profit Outlook

Reuters on MSN · 1d

Pfizer raises 2025 profit forecast as cost-cutting program gains traction

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.

Wall Street Journal · 1d

Pfizer Raises Profit Outlook Despite Uncertainty Over Tariffs, Drug Prices

Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.

MarketWatch on MSN · 1d

Pfizer boosts profit estimate, even as the drug giant absorbs tariffs

Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% jump in second-quarter revenue on strength in its Vyndaqel heart medication and its COVID-19 drugs.

20hon MSN

HHS phases out mRNA vaccine trials for COVID-19, bird flu

HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine ...

Buy Pfizer Stock At $24?

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

5don MSN

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Free Malaysia Today on MSN1d

Pfizer’s earnings boosted by Covid-19 products, lower expenses

Pfizer was among the 17 companies that received a July 31 letter from president Donald Trump demanding lower drug prices.

13hon MSN

RFK Jr cancels $500m in funding for mRNA vaccines for diseases like Covid

The US Department of Health and Human Services (HHS) plans to cancel $500m (£376m) in funding for mRNA vaccines being ...

PhillyVoice20h

Technology advanced by Penn scientists led to COVID shots. Five years later, RFK Jr. is slashing mRNA vaccine research

The Health and Human Services secretary cancelled nearly $500 million in contracts related to the development of future ...

MedPage Today on MSN2d

Did FDA Pick the Wrong COVID Vaccine Strain Last Season?

The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...

Free Malaysia Today on MSN13h

US axes mRNA vaccine contracts, casting doubt on technology which helped end Covid-19 pandemic

This marks US Health Secretary Robert F. Kennedy Jr’s latest effort to weave vaccine scepticism into US policy. Read more at ...

2don MSN

Pfizer stock pops as big pharma giant delivers post-COVID comeback

Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.

1 Reason to Buy Pfizer (PFE) Stock

And better still, healthy and growing dividend-paying stocks tend to increase their payouts over time. Pfizer's total annual ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results